LADAF is a group of researchers that apply science and technology to develop new foods and supplements to improve human health and life quality. Our research is mainly based on omega 3 fatty acids, plant sterols and trans-resveratrol as supplements, added to foods or combined with drugs to prevent or regress atherosclerosis.
LADAF is a group of researchers that apply science and technology to develop new foods and supplements to improve human health and life quality. Our research is mainly based on omega 3 fatty acids, plant sterols and trans-resveratrol as supplements, added to foods or combined with drugs to prevent or regress atherosclerosis.
Projects developed with food or pharmaceutical companies following all steps of the business plan, from TRL1 to TRL9.
Determination of fatty acids and sterols by GC/MS and oxidative stress biomarkers by HPLC.
To apply statistical tools to plan experiments and data analysis.
In company training about the statistical planning for optimization of products and process.
All researchers of our team are academics
Validated Methods
Affordable and negotiable prices
Ladaf has innovative projects developed by our team that are great opportunities to invest!
Check our current projects!
Treatment to reduce atherosclerosis
Anti-PECAM-1Surface-Functionalized Metal-Complex Multi-Wall Nanocapsules containing DHA as algae oil in their core were developed by our group and showed 94.80% of conjugation efficiency, at least 1 h of stability at 200 µg/mL and were uptaken by HUVECs.
Recent results showed that our nanocapsules were in vitro phagocyted by macrophages (RAW 264.7 cells) and changed the cells from pro-inflammatory (M1) to anti-inflammatory (M2) phenotype. If you have interest on our project, more information can be obtained in the pdf document.
Go to Business Plan